Novel targets for the treatment of atherosclerosis

Area of Science:

• Cardiovascular Medicine
• Inflammation Research
• Pharmacology

Background:

• Atherosclerosis is a primary cause of mortality globally, necessitating advanced therapeutic strategies.
• Inflammation plays a critical, undeniable role in the development of atherosclerotic plaques.
• C-reactive protein is a key inflammatory marker associated with atherosclerosis.

Purpose of the Study:

• To review emerging risk factors and therapeutic targets for atherosclerosis.
• To highlight the importance of inflammation in atherosclerosis pathogenesis.
• To discuss novel therapeutic interventions beyond traditional targets.

Main Methods:

• Literature review of studies on atherosclerosis, inflammation, and therapeutic targets.
• Analysis of the role of C-reactive protein as an inflammatory marker.
• Identification of novel therapeutic agents targeting cholesterol metabolism, inflammation, and lipid transfer.

Main Results:

• Inflammation is a central factor in atherosclerotic plaque progression.
• C-reactive protein serves as a significant indicator of atherosclerotic inflammation.
• Several novel therapeutic targets are emerging, including specific enzyme inhibitors and peptide-based therapies.

Conclusions:

• Targeting inflammation and novel pathways represents a promising future direction for atherosclerosis treatment.
• Inhibitors of cholesterol synthesis/absorption, antioxidants, and apolipoprotein A-I mimetics show therapeutic potential.
• Further research into these novel targets is crucial for developing effective anti-atherosclerosis therapies.